Cancer immunotherapy

In the past decade, immunotherapies have revolutionized the way we treat cancer by recruiting the body's own defense mechanisms to attack halt tumor growth. Scientists at UChicago Medicine are leading the field of immunology, from basic research that aims to understand how the immune system works at the molecular level to clinical trials that are testing the newest and most promising therapies.

Featured

T Cells

Teaching our immune system how to fight cancer

New ‘plug-and-play’ cell design could revolutionize cancer immunotherapy An illustration of a pink and purple immune cell against a pale background

New ‘plug-and-play’ cell design could revolutionize cancer immunotherapy

Engineered immune cells could give doctors new precision when fighting tumors

Decades in the making, cancer immunotherapy is on the rise Teenage oncology patient talking with doctor.

Decades in the making, cancer immunotherapy is on the rise

New therapies harness the body’s cancer-fighting powers, but they don't work for everyone. UChicago experts aim to change that

The doctor ushering in a new era of cancer research and care at UChicago Adekunle Odunsi

The doctor ushering in a new era of cancer research and care at UChicago

Prof. Kunle Odunsi leads Comprehensive Cancer Center as new pavilion construction begins

Study: Nutrient found in meat and dairy improves immune response to cancer 3D rendering of a large bumpy white cell with two small red cells attached to it, on a black background

Study: Nutrient found in meat and dairy improves immune response to cancer

Polsky Center supports UChicago scholar in founding immunotherapy startup Thomas Gajewski

Polsky Center supports UChicago scholar in founding immunotherapy startup

Innovative drug delivery improves effectiveness of cancer immunotherapy Cancer tumor

Innovative drug delivery improves effectiveness of cancer immunotherapy

Specific microbes in digestive tract can boost success for cancer immunotherapy Thomas Gajewski

Specific microbes in digestive tract can boost success for cancer immunotherapy

Next-generation cancer drugs boost immunotherapy responses

Next-generation cancer drugs boost immunotherapy responses

<p>Prof. Thomas Gajewski assesses prospects for new cancer therapies</p>


Nature

Prof. Thomas Gajewski honored for pioneering cancer research Patient talking to Dr. Gajewski

Prof. Thomas Gajewski honored for pioneering cancer research

UChicago, Evelo Biosciences to develop microbiome-based cancer therapy Human gut microbiome under the microscope

UChicago, Evelo Biosciences to develop microbiome-based cancer therapy